ASX joins global vaccine rally with 2.2% surge

Summary

• The ASX jumped by 2.2% - or $42 billion - at Tuesday's open on the back of encouraging coronavirus vaccine news. Gains soon eased to 1.5%
• Pfizer says early data for its experimental COVID-19 vaccine suggests the shots may be 90% effective 
• The S&P 500 rose 1.2% overnight and closed just shy of a record, while the Dow jumped 3%. The tech-heavy Nasdaq slipped 1.5%. European markets surged
• Energy, property, and travel-aligned ASX stocks jumped early. Goldminers were hammered as the precious metal slipped, while tech stocks also fell